Korean Drug Balance Sheet Health
Financial Health criteria checks 6/6
Korean Drug has a total shareholder equity of ₩80.4B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩93.5B and ₩13.2B respectively. Korean Drug's EBIT is ₩247.2M making its interest coverage ratio -0.3. It has cash and short-term investments of ₩20.1B.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | -0.3x |
| Cash | ₩20.13b |
| Equity | ₩80.36b |
| Total liabilities | ₩13.16b |
| Total assets | ₩93.53b |
Recent financial health updates
No updates
Recent updates
Unpleasant Surprises Could Be In Store For Korean Drug Co., Ltd.'s (KOSDAQ:014570) Shares
Jun 19
Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?
Mar 11Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?
Feb 19
Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?
Jan 11Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?
Dec 24Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today
Dec 06Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 18Financial Position Analysis
Short Term Liabilities: A014570's short term assets (₩68.5B) exceed its short term liabilities (₩10.0B).
Long Term Liabilities: A014570's short term assets (₩68.5B) exceed its long term liabilities (₩3.2B).
Debt to Equity History and Analysis
Debt Level: A014570 is debt free.
Reducing Debt: A014570 had no debt 5 years ago.
Debt Coverage: A014570 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A014570 has no debt, therefore coverage of interest payments is not a concern.